Bd, magnolia medical technologies announce commercial collaboration to help reduce blood culture contamination and improve testing accuracy

Franklin lakes, n.j. , oct. 18, 2022 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, and magnolia medical technologies, inc., today announced a co-exclusive commercial agreement aimed at helping u.s. hospitals reduce blood culture contamination to help improve testing accuracy and ultimately improve clinical outcomes.
BDX Ratings Summary
BDX Quant Ranking